Suppr超能文献

脓毒症治疗捆绑包各组成部分完成时间的时间轴及其与脓毒性休克结局的关系。

Timeline of sepsis bundle component completion and its association with septic shock outcomes.

机构信息

Division of Pulmonary and Critical Care Medicine, Department of Medicine, Mayo Clinic, Rochester, MN, United States of America; Department of Critical Care Medicine, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China.

Department of Critical Care Medicine, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China.

出版信息

J Crit Care. 2020 Dec;60:143-151. doi: 10.1016/j.jcrc.2020.07.027. Epub 2020 Aug 7.

Abstract

PURPOSE

To assess the impact of the timeline of sepsis bundle completion with clinical outcomes in septic shock.

MATERIALS AND METHODS

We retrospectively studied adult (≥18 years) patients with septic shock from January 1, 2006, through May 31, 2018, who were admitted to the intensive care unit in Mayo Clinic, Rochester. We divided patients into three groups based on the SSC compliant 1) <1h, 2) 1.1 to 3 h, 3) >3 h after the time of septic shock diagnosis.

RESULTS

We enrolled 1052 septic shock patients, among 8% were in group 1, 26% in group 2, and the remaining in group 3. Those who completed all bundle components within 3 h had the lowest 28-day mortality (17.5% vs. 31.4%, p < .001) and higher survival at 90 days (HR = 0.67; 95% CI 0.55-0.80; p < .001). Sepsis bundle completion in <1 h had no significant advantage in 28-day mortality (21.5% vs.15.9%, p = .4) or 90-day survival compared with group 2 (HR = 1.08; 95% CI 0.77-1.53; p = .6).

CONCLUSIONS

We showed an association between the completion of SSC bundle components within three hours with lower mortality or earlier shock reversal. This relationship was not evident when compared to bundle completion in 1 h vs. within 3 h.

摘要

目的

评估脓毒症集束治疗完成时间与脓毒性休克临床结局的关系。

材料和方法

我们回顾性研究了 2006 年 1 月 1 日至 2018 年 5 月 31 日期间在梅奥诊所罗切斯特院区重症监护病房收治的成年(≥18 岁)脓毒性休克患者。我们根据 SSC 达标情况将患者分为三组:1)<1 小时,2)1.1-3 小时,3)>3 小时。

结果

我们共纳入 1052 例脓毒性休克患者,其中 8%的患者在第 1 组,26%的患者在第 2 组,其余的患者在第 3 组。在 3 小时内完成所有集束治疗的患者 28 天死亡率最低(17.5% vs. 31.4%,p < 0.001),90 天生存率更高(HR=0.67;95%CI 0.55-0.80;p < 0.001)。在 1 小时内完成集束治疗与第 2 组相比,在 28 天死亡率(21.5% vs. 15.9%,p = 0.4)或 90 天生存率(HR=1.08;95%CI 0.77-1.53;p = 0.6)方面没有显著优势。

结论

我们发现,在 3 小时内完成 SSC 集束治疗与死亡率降低或休克早期逆转有关。与 1 小时内完成集束治疗相比,在 3 小时内完成集束治疗与死亡率或休克早期逆转之间的关系并不明显。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验